| Cat. No. |
Product Name |
Information |
| PC-25531 |
GLUT8 inhibitor P20
GLUT8 inhibitor
|
GLUT8 inhibitor P20 is a selective inhibitor of glucose transporter GLUT8 (SLC2A8) with IC50 of 2.1 uM, 2.9-fold selective over GLUT2. |
| PC-49286 |
SW157765
GLUT8 inhibitor
|
SW157765 (SW-157765) is a potent, specific inhibitor of glucose transporter GLUT8 (SLC2A8) with Kd of 200 nM, shows sensitivity to KRAS/KEAP1 double mutant NSCLC cells. |
| PC-47016 |
Glutipyran
GLUT inhibitor
|
Glutipyran is a small-molecule glucose transporter inhibitor, inhibits glycolytic activity and cell growth in human pancreatic cancer cells. |
| PC-73034 |
Glutor
GLUT inhibitor
|
Glutor (Glucose uptake inhibitor Glutor) is a novel highly potent glucose uptake inhibitor (IC50=10.8 nM) that selectively targets glucose transporters GLUT-1, -2, and -3. |
| PC-72556 |
KL-11743
GLUT inhibitor
|
KL-11743 (KL11743) is a potent, selective, orally bioavailable inhibitor of class I glucose transporters with IC50 of 115/137/90/68 nM for GLUT1/2/3/4, respectively. |
| PC-72387 |
DRB18
pan-GLUT inhibitor
|
DRB18 (DRB-18) is a potent, pan-class I glucose transporter (GLUT) inhibitor, reduces glucose uptake in HEK293 cell lines expressd single GLUT1-4 with IC50 of 0.9-8.8 uM. |
| PC-35327 |
WZB117
GLUT1 inhibitor
|
WZB117 (WZB-117) is a small-molecule inhibitor of glucose transporter 1 (GLUT1, SLC2A1), inhibits glucose transport and cancer cell proliferation with IC50 of 10 uM. |
| PC-62895 |
Fasentin
GLUT4 inhibitor
|
Fasentin is a novel inhibitor of glucose uptake (GLUT) that sensitizes cancer cells to FAS-induced cell death, preferentially inhibits GLUT4 (IC50=68 uM) over GLUT1. |
| PC-60884 |
GLUT4-IN-17
GLUT4 inhibitor
|
GLUT4-IN-17 is a potent, selective glucose transporter 4 (GLUT4) inhibitor with IC450 of 10.8 uM, inhibits MM cell proliferation. |
| PC-45543 |
STF-31
GLUT1 inhibitor
|
STF-31 is a selective GLUT1 inhibitor with IC50 of 1 uM, does not bind to other glucose transporters. |
| PC-42031 |
BAY-876
GLUT1 inhibitor
|
BAY-876 (BAY876) is a potent, highly selective and oral bioavailable GLUT1 inhibitor with IC50 of 2 nM. |
| PC-25569 |
MSNBA
GLUT5 inhibitor
|
MSNBA is a specific inhibitor of glucose transporter GLUT5, competitively inhibits GLUT5 fructose uptake with Ki of 3.2 uM, inhibits GLUT5 fructose transport in proteoliposomes with IC50 of 0.1 uM. |
